News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

May 15, 2024

Lipidor AB (publ) publishes annual report for 2023

STOCKHOLM, Sweden, 15th May 2024 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its annual report for the financial year 2023. The report is available on the company's website lipidor.se and in the attached pdf (in Swedish). To read the report in full (in Swedish) click…

January 14, 2019

Lipidor AB successfully completes private placement of 20 MSEK

14 January 2019, Stockholm, Sweden. Lipidor AB, a Swedish drug development company with an ongoing fully financed Phase III study for a…

October 4, 2018

Lipidor: First Patient In for Phase III trial of Calcipotriol Spray, a new high-comfort, high-control anti-psoriasis spray

Stockholm, Sweden 4 October: Psoriasis is a chronic disease affecting 2-4% of the world’s population. A new anti-psoriasis spray now in a…

September 3, 2018

Lipidor: New CEO at helm as company gears up for IPO

Ola Holmlund begins as Lipidor’s new CEO on September 1. With a powerful track record in Business Development and Strategic Sales, Holmlund…

August 23, 2018

Lipidor gets go-ahead for Phase III Clinical Study of new Calcipotriol Spray treatment for psoriasis

India’s CDSCO (Central Drugs Standard Control Organization) has approved Phase III Trials of a new topical anti-psoriatic spray developed by Swedish company…

April 10, 2018

Lipidor AB strengthens its board and aims for an IPO in 2019

Lipidor AB, a pharmaceutical company developing innovative products based on its proprietary AKVANO® technology, announces today its plan to list the company…